Syringes Market Size & Growth Forecast 2027–2036, By Segments (Material, Application, Preparation, End Use, Size), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Syringes Market size was assessed at USD 25.57 Billion in 2026 and is poised to grow at 11.34% CAGR between 2027 and 2036, crossing USD 74.86 Billion by 2036. The industry revenue for 2027 is calculated at USD 28.08 Billion.
Get more details on this report
Request Free Sample ReportSyringes Market Intelligence Snapshot
Regional Market Dynamics
- Asia Pacific led the market in 2026 due to expanding healthcare infrastructure, rising healthcare expenditure, injectable treatment demand, and improving medical manufacturing capabilities.
- Growth is supported by expanding vaccination programs, injectable drug administration, hospital-based care, infection-prevention efforts, and broader access to advanced medical technologies.
Segment Momentum
- Plastic/polymer syringes held 64.13% share in 2026 and lead due to single-use adoption, cost efficiency, manufacturing flexibility, and infection prevention requirements.
- Biologics accounted for 57.98% in 2026 and drives demand through growing use of advanced injectable therapies requiring accurate dosing and reliable drug delivery systems.
Market Expansion Drivers
- Rising vaccination programs and chronic disease treatments increasing global syringe demand
- Growing biologics and biosimilars research accelerating high-precision injectable delivery requirements
- Advancements in safety-engineered syringes reducing needlestick injuries in clinical environments
Leading Market Participants
- Key players in the syringes market include Becton, Dickinson and Company (USA), Terumo Corporation (Japan), Nipro Corporation (Japan), Gerresheimer AG (Germany), West Pharmaceutical Services, Inc. (USA), ICU Medical, Inc. (USA), Cardinal Health, Inc. (USA), SCHOTT Pharma AG & Co. KGaA (Germany), Shandong Weigao Group Medical Polymer Co., Ltd. (China), Daikyo Seiko, Ltd. (Japan)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 25.57 Billion
- 2027 Estimated Market Size: USD 28.08 Billion
- Projected Market Size: USD 74.86 Billion by 2036
- Growth Forecast: 11.34% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: Asia Pacific
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Plastic/polymers (Material) | Biologics (Application) | Ready to Use (RTU) (Preparation) | Hospitals & Clinics (End Use) | 3 Ml - 5 Ml (Size)
- Emerging Opportunity Segment: Plastic/polymers (Material) | Biologics (Application) | Ready to Use (RTU) (Preparation) | Pharma & Biotech Companies (End Use) | 1 Ml - 2 Ml (Size)
Market Growth Drivers and Industry Trends
Rising vaccination programs and chronic disease treatments increasing global syringe demand
Expanding immunization initiatives and the increasing prevalence of long-term medical conditions are creating sustained demand for injectable therapies across healthcare systems. The syringes market growth is driven by the continuous need for reliable drug administration in vaccination campaigns, diabetes management, autoimmune disorders, and other treatments requiring frequent injections. Healthcare providers are also strengthening inventory planning to ensure uninterrupted availability of disposable syringes for routine clinical use, while broader access to preventive healthcare services and expanded treatment coverage are increasing procurement across hospitals, clinics, and public health institutions.
Growing biologics and biosimilars research accelerating high-precision injectable delivery requirements
As pharmaceutical innovation shifts toward complex biologics and biosimilar therapies, manufacturers require delivery devices capable of maintaining dosing accuracy and product integrity. This trend will propel the syringes market growth by encouraging the adoption of precision-engineered syringes designed to support sensitive injectable formulations. Research organizations, pharmaceutical developers, and healthcare facilities increasingly prioritize advanced syringe designs that minimize dosing variability, reduce contamination risks, and improve compatibility with specialized drug formulations used in clinical development and commercial treatment.
Advancements in safety-engineered syringes reducing needlestick injuries in clinical environments
Healthcare institutions are placing greater emphasis on occupational safety, leading to wider adoption of syringe technologies that incorporate protective mechanisms for healthcare professionals. Within the syringes market, innovations such as retractable needles, shielding systems, and passive safety features are becoming integral to clinical practice because they help reduce accidental needlestick injuries during medication administration and disposal. These enhanced designs also support infection control protocols, improve workplace safety standards, and simplify compliance with healthcare facility policies governing the handling of sharps.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising vaccination programs and chronic disease treatments increasing global syringe demand | 2% | High | Asia Pacific, Africa | High | Near Term |
| Growing biologics and biosimilars research accelerating high-precision injectable delivery requirements | 1.7% | High | North America, Europe | High | Mid Term |
| Advancements in safety-engineered syringes reducing needlestick injuries in clinical environments | 1.4% | High | Europe, North America | High | Near Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
Asia Pacific (Largest & Fastest-Growing Region)
Asia Pacific dominated the syringes market and held the largest share in 2026, while also representing the fastest-growing regional market. The region's strong position is supported by expanding healthcare infrastructure, rising healthcare expenditure, and increasing demand for injectable treatments across hospitals, clinics, and other medical facilities. A large patient population, growing prevalence of chronic diseases, and greater access to healthcare services are sustaining demand for syringes, while improvements in medical manufacturing capabilities are strengthening regional supply.
Continued expansion of vaccination programs, injectable drug administration, and hospital-based care is further supporting market development across Asia Pacific. Increasing emphasis on infection prevention and safe medical-device practices is encouraging the adoption of quality-engineered disposable syringes, while healthcare modernization and expanding clinical capacity are broadening utilization. These trends, combined with improving access to advanced medical technologies, are expected to maintain strong regional momentum.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Advanced Healthcare SupplyThe U.S. syringes market emphasizes reliable supply for hospitals, vaccination programs, and specialty drug delivery. Healthcare providers in the U.S. increasingly adopt safety-engineered syringes and prefilled formats to improve clinical efficiency and reduce needlestick risks.
Germany 🇩🇪
Precision Medical ManufacturingGermany prioritizes high-quality syringe production aligned with stringent medical device standards and pharmaceutical requirements. German manufacturers focus on precision manufacturing and compatibility with injectable biologics and advanced healthcare applications.
Japan 🇯🇵
High-Quality Injection SystemsJapan supports demand for syringes through advanced healthcare delivery and an expanding range of injectable therapies. Medical device companies in Japan continue improving product reliability, material quality, and patient safety across clinical settings.
South Korea 🇰🇷
Biopharma Delivery SupportSouth Korea strengthens the syringes market through expanding biopharmaceutical manufacturing and healthcare modernization. Domestic producers increasingly develop syringe solutions compatible with biologics, vaccines, and automated pharmaceutical filling operations.
France 🇫🇷
Hospital Safety FocusFrance emphasizes syringe procurement that supports infection prevention, medication accuracy, and healthcare worker safety. Healthcare institutions across France continue adopting advanced disposable and safety syringe technologies within routine clinical practice.
Italy 🇮🇹
Clinical Care IntegrationItaly maintains steady demand for syringes across hospitals, outpatient care, and immunization programs. Italian healthcare providers prioritize dependable medical consumables that support efficient treatment delivery while meeting evolving regulatory expectations.
Segment Leadership and Growth Trends
Syringes Market Share (%), Preparation, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportMaterial Segment Analysis: Plastic/polymers (Largest & Fastest-Growing Segment)
Holding the largest share of the syringes market, the plastic/polymer syringes segment accounted for 64.13% in 2026 and also represented the fastest-growing material category. Its leadership is driven by the widespread adoption of single-use medical devices that help minimize cross-contamination risks while supporting stringent infection prevention standards. Plastic and polymer syringes offer advantages including lightweight construction, manufacturing flexibility, cost efficiency, and compatibility with high-volume production. Rising healthcare utilization, expanding immunization programs, and increasing demand for safe injectable drug delivery continue to reinforce the segment’s dominant position.
Application Segment Analysis: Biologics (Largest & Fastest-Growing Segment)
The biologics application segment led the syringes market, capturing 57.98% in 2026, while also remaining the fastest-growing application. The increasing development and administration of biologic therapies for chronic and complex diseases have significantly expanded the need for reliable, high-quality syringe systems capable of preserving drug stability and ensuring accurate dosing. Growth in specialty pharmaceuticals, personalized medicine, and injectable biologic treatments continues to strengthen demand for syringes specifically designed to meet the stringent handling requirements associated with these advanced therapies.
Preparation Segment Analysis: Ready to Use (RTU) (Largest & Fastest-Growing Segment)
The syringes market was led by the ready-to-use (RTU) preparation segment, which held the largest share in 2026 while also emerging as the fastest-growing preparation category. RTU syringes eliminate additional sterilization steps, enabling healthcare providers and pharmaceutical manufacturers to improve operational efficiency while maintaining high standards of sterility and product safety. Their growing adoption is supported by increasing demand for pre-sterilized delivery systems in pharmaceutical manufacturing, expanding use in injectable therapies, and the industry's continued emphasis on reducing contamination risks and streamlining production workflows.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Material | Glass, Plastic/polymers | Plastic/polymers | Plastic/polymers |
| Application | Small Molecules, Biologics, Diagnostics | Biologics | Biologics |
| Preparation | Ready to Use (RTU), Ready to Sterilize (RTS) | Ready to Use (RTU) | Ready to Use (RTU) |
| End Use | Hospitals & Clinics, Pharma & Biotech Companies, Contract Development and Manufacturing Organizations (CDMOs), Diagnostic Laboratories, Others | Hospitals & Clinics | Pharma & Biotech Companies |
| Size | <1 Ml, 1 Ml - 2 Ml, 3 Ml - 5 Ml, 6 Ml - 10 Ml, 10 - 20 Ml, 20 - 30 Ml, >30 Ml | 3 Ml - 5 Ml | 1 Ml - 2 Ml |
Competitive Landscape and Market Positioning
Prominent players in the syringes market:
- Becton Dickinson and Company (USA)
- Terumo Corporation (Japan)
- Nipro Corporation (Japan)
- Gerresheimer AG (Germany)
- West Pharmaceutical Services, Inc. (USA)
- ICU Medical, Inc. (USA)
- Cardinal Health, Inc. (USA)
- SCHOTT Pharma AG & Co. KGaA (Germany)
- Shandong Weigao Group Medical Polymer Co., Ltd. (China)
- Daikyo Seiko Ltd. (Japan)
Procurement priorities across healthcare systems are steadily reshaping competitive dynamics, with manufacturers moving beyond volume-based competition to emphasize product safety, manufacturing consistency, and regulatory compliance. Demand for designs that reduce needlestick injuries and improve clinical workflow is accelerating investment in advanced engineering and automated production capabilities, creating higher entry barriers for suppliers lacking large-scale quality systems. At the same time, healthcare providers are placing greater value on dependable supply continuity, encouraging manufacturers to strengthen regional production networks and diversify sourcing strategies. As sustainability expectations gain influence within medical procurement, recyclable materials and waste-reduction initiatives are becoming additional points of differentiation alongside clinical performance.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Becton Dickinson and Company (USA) | |||||||
| Terumo Corporation (Japan) | |||||||
| Nipro Corporation (Japan) | |||||||
| Gerresheimer AG (Germany) | |||||||
| West Pharmaceutical Services Inc. (USA) | |||||||
| ICU Medical Inc. (USA) | |||||||
| Cardinal Health Inc. (USA) | |||||||
| SCHOTT Pharma AG & Co. KGaA (Germany) | |||||||
| Shandong Weigao Group Medical Polymer Co. Ltd. (China) | |||||||
| Daikyo Seiko Ltd. (Japan) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Celltrion Pharmaceutical | Jul-25 | Celltrion Pharmaceutical is investing 2 trillion won to expand pharmaceutical production infrastructure in Osong, South Korea. The project includes phased capacity expansion for pre-filled syringe (PFS) manufacturing, significantly bolstering the company's capabilities in the injectable drug market and supporting long-term production growth. |
| ROIS | Jul-25 | ROIS acquired Bristol Myers Squibb’s sterile injectable manufacturing and packaging facility in Phoenix, Arizona. This strategic acquisition enhances the company's domestic manufacturing capacity and broadens its operational footprint for sterile injectable products within the United States. |
| PCI Pharma Services | Jul-25 | PCI Pharma Services announced a capital investment exceeding $365 million across Europe and North America. The initiative focuses on expanding infrastructure for the assembly and packaging of drug-device combination products, with a specific emphasis on scaling capacity for advanced injectable delivery systems. |
| Alvotech | Jul-25 | Alvotech acquired pharmaceutical packaging firm Ivers-Lee to integrate assembly and packaging capabilities for complex delivery devices, including autoinjectors and pre-filled syringes. This move strengthens the company's internal biologics packaging infrastructure and supports the commercialization of its portfolio. |
| Boston Oncology | Jul-25 | Boston Oncology is investing $70 million to expand manufacturing capacity for biologics and complex injectable products in Saudi Arabia. The development represents a strategic push to enhance regional production capabilities and address the increasing demand for advanced injectable therapeutics in the market. |
| BD | Jul-25 | BD committed a $10 million investment to increase U.S. manufacturing capacity for syringes and needles. This initiative is aimed at reinforcing domestic production resilience and addressing critical supply chain requirements for essential medical devices within the healthcare system. |
| Stevanato Group | Jul-25 | Stevanato Group achieved a major milestone by initiating commercial production at its Fishers manufacturing facility. This expansion significantly boosts the company's output capacity for pharmaceutical glass vials and pre-filled syringes, directly addressing the sustained high demand for high-quality drug delivery components. |
| Sharps Technology | May-25 | Sharps Technology acquired the InjectEZ specialty syringe manufacturing assets from Nephron Pharmaceuticals. The acquisition provides the company with established production capabilities in South Carolina, effectively expanding its manufacturing footprint and strengthening its competitive position in the specialty syringe sector. |
| SCHOTT Pharma | Apr-25 | SCHOTT Pharma commissioned a new production facility in Hungary specialized in prefillable glass syringes. This strategic expansion adds critical global manufacturing capacity for high-value pharmaceutical packaging, supporting the broader industry shift toward advanced delivery solutions for complex injectable medications. |
| BD | Mar-24 | BD entered a strategic partnership with CDMO ten23 health to integrate RFID technology for tracking prefillable syringes. The collaboration focuses on enhancing supply chain reliability and patient safety by improving the efficiency of syringe inventory management through digital innovation. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Syringes Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Tip Design | Luer Lock, Luer Slip, Catheter Tip, Other Specialized Tips |
| Safety Feature | Standard Syringes, Safety-Engineered Syringes, Passive Safety Syringes, Active Safety Syringes |
| Packaging Configuration | Bulk Packaging, Unit Packaging, Sterile Barrier Packaging, Kit/Procedure Packaging |
Syringes Market — report.custom
| Custom Chapter | Custom Details |
|---|---|
| Healthcare Procurement and Tender Intelligence |
|
| Safety Syringe Adoption Roadmap |
|
| Prefilled and Drug-Delivery Substitution Assessment |
|
Need a different cut of the data?
Request Custom ResearchHow large is the syringes market?
What is the expected industry size of syringes by 2036?
How are expanding vaccination programs and chronic disease treatments influencing syringe procurement?
Why are advanced syringe designs gaining importance in pharmaceutical and clinical applications?
Why are plastic/polymer syringes gaining strong market adoption?
How is the biologics segment influencing syringe demand?
Why does Asia Pacific lead the syringes market?
What is driving syringes market growth across Asia Pacific?
Who holds a significant market share in the syringes landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization